AEON Biopharma's total assets for Q3 2025 were $8.73M, a decrease of -25.11% from the previous quarter. AEON total liabilities were $28.61M for the fiscal quarter, a 3.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.